Clinical Trial: A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754175) titled 'A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial' on Aug. 04.

Brief Summary: A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Study Start Date: July 20

Study Type: OBSERVATIONAL

Condition: Knee Osteoarthritis

Recruitment Status: RECRUITING

Sponsor: Kang Stem Biotech Co., Ltd.

Published by HT Digital Content Services with permission from He...